Management of Type 2 diabetes mellitus in primary care
作者： Joan Rachel Somerville McDowell
DOI:
关键词:
摘要: Background: The incidence and prevalence of diabetes mellitus (diabetes) is increasing globally. The majority people have type 2 diabetes, initially managed by lifestyle changes the gradual introduction oral, followed subcutaneous, medications. Due to numbers with different models care management been utilised within United Kingdom. One Health Board Scotland received funding undertake a service redesign whereby responsibility for was transferred from secondary primary care, referral specialist services based on clinical need. Aim: The aim this thesis present body published work an evaluation research study change in delivery diabetes. works arisen two funded studies resulting one peer reviewed report five peer-reviewed papers international journals.
bl.uk参考文章(364)
Robert F. Coniff, Jo Ann Shapiro, Timothy B. Seaton, George A. Bray, Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus The American Journal of Medicine. ,vol. 98, pp. 443- 451 ,(1995) , 10.1016/S0002-9343(99)80343-X
Christopher M. Ryan, Dorothy J. Becker, HYPOGLYCEMIA IN CHILDREN WITH TYPE 1 DIABETES MELLITUS: Risk Factors, Cognitive Function, and Management Endocrinology and Metabolism Clinics of North America. ,vol. 28, pp. 883- 900 ,(1999) , 10.1016/S0889-8529(05)70107-9
Daniel Einhorn, Marc Rendell, James Rosenzweig, John W Egan, Annette L Mathisen, Roberta L Schneider, Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: A randomized, placebo-controlled study Clinical Therapeutics. ,vol. 22, pp. 1395- 1409 ,(2000) , 10.1016/S0149-2918(00)83039-8
M.F.M. Mitwally, N.K. Kuscu, T.M. Yalcinkaya, High ovulatory rates with use of troglitazone in clomiphene-resistant women with polycystic ovary syndrome Human Reproduction. ,vol. 14, pp. 2700- 2703 ,(1999) , 10.1093/HUMREP/14.11.2700
Carlos A Dujovne, Mark P Ettinger, J.Frederick McNeer, Leslie J Lipka, Alexandre P LeBeaut, Ramachandran Suresh, B.o Yang, Enrico P Veltri, Efficacy and safety of a potent new selective Cholesterol absorption inhibitor, Ezetimibe, in patients with primary hypercholesterolemia American Journal of Cardiology. ,vol. 90, pp. 1092- 1097 ,(2002) , 10.1016/S0002-9149(02)02798-4
I. B. Hirsch, Metformin added to insulin therapy in poorly controlled type 2 diabetes. Diabetes Care. ,vol. 22, pp. 854- 854 ,(1999) , 10.2337/DIACARE.22.5.854B
William H Dietz, Overweight and precursors of type 2 diabetes mellitus in children and adolescents The Journal of Pediatrics. ,vol. 138, pp. 453- 454 ,(2001) , 10.1067/MPD.2001.113635
Heidi Wehring, Bruce Alexander, Paul J. Perry, Diabetes mellitus associated with clozapine therapy. Pharmacotherapy. ,vol. 20, pp. 844- 847 ,(2000) , 10.1592/PHCO.20.9.844.35201
Amy M. Heck, Jack A. Yanovski, Karim Anton Calis, Orlistat, a New Lipase Inhibitor for the Management of Obesity Pharmacotherapy. ,vol. 20, pp. 270- 279 ,(2000) , 10.1592/PHCO.20.4.270.34882
Peter S Sever, Björn Dahlöf, Neil R Poulter, Hans Wedel, Gareth Beevers, Mark Caulfield, Rory Collins, Sverre E Kjeldsen, Arni Kristinsson, Gordon T McInnes, Jesper Mehlsen, Markku Nieminen, Eoin O'Brien, Jan Östergren, None, Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial The Lancet. ,vol. 361, pp. 1149- 1158 ,(2003) , 10.1016/S0140-6736(03)12948-0